info@seagull-health.com
SeagullHealth
语言:
search
new
Mobocertinib (Exkivity) Side Effect Management and Medication Storage Guide
509
Article source: Seagull Pharmacy
Mar 13, 2026

Mobocertinib (Exkivity) is a targeted therapy used for the treatment of non-small cell lung cancer with specific EGFR mutations. While it exerts therapeutic effects, it may also cause a range of side effects.

I. Common Side Effects of Mobocertinib (Exkivity)

1. Cardiac-related Side Effects

(1) The medication may cause QT interval prolongation, leading to arrhythmia, dizziness, or syncope. In rare cases, life-threatening ventricular arrhythmias may occur.

(2) Additionally, a decline in cardiac function may manifest as shortness of breath, chest pain, ankle edema, or abnormal heart rhythms.

2. Pulmonary Side Effects

(1) It may cause interstitial lung disease or pneumonia, with symptoms including new or worsening cough, difficulty breathing, chest pain, or fever.

(2) This is a serious adverse reaction that requires high vigilance.

3. Gastrointestinal Side Effects

(1) Diarrhea is the most common adverse reaction, with a high incidence and may be severe, easily leading to dehydration and electrolyte imbalance.

(2) Others include nausea, vomiting, decreased appetite, stomatitis, and weight loss.

4. Skin and Nail Side Effects

(1) Rashes, dry skin, pruritus, paronychia (infection around the nail bed), and alopecia are relatively common.

(2) Rashes vary in morphology, ranging from mild erythema to acne-like eruptions.

5. Other Systemic Side Effects

(1) Patients often experience fatigue or weakness. Muscle or joint pain may occur.

(2) Abnormal laboratory tests include lymphopenia, elevated amylase/lipase, decreased potassium/magnesium levels, increased serum creatinine, and elevated transaminases.

II. Practical Methods to Alleviate Side Effects

1. Management of Cardiac and Pulmonary Issues

(1) During treatment, regular monitoring of electrocardiograms (ECG) and electrolytes should be conducted as directed by a healthcare provider.

(2) If new symptoms such as palpitations, dizziness, difficulty breathing, or chest pain occur, seek medical attention immediately without delay.

(3) If interstitial lung disease is suspected, the doctor may order immediate discontinuation of the medication and conduct further evaluation.

2. Management of Gastrointestinal Discomfort

(1) At the first occurrence of diarrhea, promptly start taking antidiarrheal medication (e.g., loperamide) and increase fluid and electrolyte intake to prevent dehydration.

(2) For nausea and vomiting, adjust dietary habits by eating small, frequent meals and avoiding greasy foods.

(3) Patients with stomatitis can use a mild mouthwash to maintain oral cleanliness.

3. Skin and Nail Care

(1) Keep the skin clean and moisturized, using mild, non-irritating skincare products.

(2) Avoid scratching when a rash appears; consult a doctor for topical medication if necessary.

(3) Pay attention to hand hygiene when handling paronychia, wear loose footwear, and seek professional care if needed.

(4) Incorporate daily sun protection.

4. Improvement of Overall Well-being

(1) To combat fatigue, balance activity and rest with mild exercise such as walking.

(2) A balanced diet with small, frequent meals helps maintain strength and weight.

(3) If pain affects daily life, inform the doctor for appropriate analgesic medication.

5. Regular Monitoring and Communication

(1) Strictly follow medical advice and attend regular follow-up appointments for blood tests, liver and kidney function tests, and ECG monitoring.

(2) Develop a habit of recording daily symptoms (e.g., frequency of bowel movements, rash condition, level of fatigue) and communicate detailed information to the doctor during follow-ups to facilitate timely adjustment of the treatment plan.

III. Storage Requirements for Mobocertinib (Exkivity)

1. Storage Environment

(1) The medication should be stored at room temperature, with an ideal temperature range of 20°C to 25°C (68°F to 77°F).

(2) For short-term transport, temporary exposure to an environment of 15°C to 30°C (59°F to 86°F) is acceptable.

2. Safety Precautions

(1) Ensure all medications are kept out of the reach and sight of children to prevent accidental ingestion.

(2) Keep the medication bottle tightly closed in its original packaging to avoid light and moisture.

3. Disposal and Transport

(1) Do not use expired medication.

(2) When traveling, carry the medication personally and avoid placing it in checked luggage to prevent extreme temperatures from affecting efficacy.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Mobocertinib(Exkivity)
Mobocertinib(Exkivity)
Adult patients with locally advanced or metastatic non-small cell lung cancer...
WeChat Scan
Free Inquiry
Recommended Articles
Common and Serious Adverse Effects of Kygevvi
Kygevvi provides significant survival benefits for patients with the rare disease TK2 deficiency, but the treatment may be accompanied by various adverse effects, with gastrointestinal reactions and l...
What are the indications for Kygevvi?
Kygevvi is a fixed-dose combination medication used for the treatment of a specific rare disease, primarily indicated for patients with TK2 deficiency.I. Indications of KygevviThe indications for Kyge...
Side Effects of Selpercatinib (Retevmo)
Selpercatinib (Retevmo) is an oral, selective RET kinase inhibitor, indicated for the treatment of non‑small cell lung cancer, medullary thyroid carcinoma, and other thyroid cancers with RET gene fusi...
What are the precautions for the use of Selpercatinib (Retevmo)?
Selpercatinib (Retevmo) is a kinase inhibitor indicated for non-small cell lung cancer, medullary thyroid carcinoma, and thyroid cancer positive for RET gene fusion or mutation.What are the precaution...
Mobocertinib (Exkivity) Medication Guidance and Health Management
Mobocertinib (Exkivity) is a targeted therapy for non-small cell lung cancer (NSCLC) with specific EGFR exon 20 insertion mutations.I. Dosage and Administration of Mobocertinib (Exkivity)Standard Dosa...
Entacapone User Guide: Side Effects and Management
Entacapone is a medication used for the treatment of Parkinson's disease. It is often used in combination with levodopa/carbidopa to enhance the therapeutic effect of levodopa by inhibiting the CO...
Entacapone Medication Guide and Healthy Living Recommendations
Entacapone is an adjunctive medication used in the treatment of Parkinson's disease and must be administered in combination with levodopa/carbidopa.I. Proper Dosage and Administration of Entacapon...
Adverse Reactions of Atovaquone (Mepron)
Atovaquone (Mepron) demonstrates significant efficacy in lipid-lowering therapy but may also induce various adverse reactions.I. Adverse Reactions of Atovaquone (Mepron)1. Serious Adverse Reactions1.1...
Related Articles
Mobocertinib (Exkivity) Medication Guidance and Health Management
Mobocertinib (Exkivity) is a targeted therapy for non-small cell lung cancer (NSCLC) with specific EGFR exon 20 insertion mutations.I. Dosage and Administration of Mobocertinib (Exkivity)Standard Dosa...
Mobocertinib (Exkivity) Side Effect Management and Medication Storage Guide
Mobocertinib (Exkivity) is a targeted therapy used for the treatment of non-small cell lung cancer with specific EGFR mutations. While it exerts therapeutic effects, it may also cause a range of side ...
What Are the Indications for Mobocertinib (Exkivity)?
Mobocertinib (Exkivity) is a new-generation EGFR inhibitor that provides an important treatment option for patients with specific mutations. As an innovative drug approved in the United States in 2021...
What Are the Purchase Channels for Mobocertinib (Exkivity)?
Mobocertinib (Exkivity) is a targeted drug used for the treatment of advanced non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations. With its increasingly widespread clinical applic...
What are the common side effects of Mobocertinib?
Mobocertinib has been approved by the National Medical Products Administration (NMPA) of China for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (...
Precautions for Mobocertinib Use
Mobocertinib is a drug that is commonly used to treat lung cancer, but there are some important things that patients need to be aware of when using it. Patients must use Mobocertinib strictl...
The efficacy and effects of Mobocertinib
Mobocertinib is the first specially designed oral TKI that selectively targets EGFR exon 20 insert mutations, which obtains selectivity by targeting proteins near the α-C-helix, and exerts anti-tumor ...
What is the therapeutic effect of Mobocertinib(Exkivity)?
Mobocertinib(Exkivity) is an innovative targeted therapy designed for patients with non-small cell lung cancer (NSCLC), particularly those harboring epidermal growth factor receptor (EGFR) exon 20 ins...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • haiousales@gmail.com
Welcome to consult
Seagull Pharmacy.,Ltd All rights reserved